Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Randomized Trial of Marine n-3 Polyunsaturated Fatty Acids for the Prevention of Cerebral Small Vessel Disease and Inflammation in Aging (PUFA Trial): Rationale, Design and Baseline Results.

Bowman GL, Silbert LC, Dodge HH, Lahna D, Hagen K, Murchison CF, Howieson D, Kaye J, Quinn JF, Shinto L.

Nutrients. 2019 Mar 29;11(4). pii: E735. doi: 10.3390/nu11040735.

2.

Targeted Assessment of Enlargement of the Perivascular Space in Alzheimer's Disease and Vascular Dementia Subtypes Implicates Astroglial Involvement Specific to Alzheimer's Disease.

Boespflug EL, Simon MJ, Leonard E, Grafe M, Woltjer R, Silbert LC, Kaye JA, Iliff JJ.

J Alzheimers Dis. 2018;66(4):1587-1597. doi: 10.3233/JAD-180367.

3.

Effects of traumatic brain injury on sleep and enlarged perivascular spaces.

Opel RA, Christy A, Boespflug EL, Weymann KB, Case B, Pollock JM, Silbert LC, Lim MM.

J Cereb Blood Flow Metab. 2018 Aug 10:271678X18791632. doi: 10.1177/0271678X18791632. [Epub ahead of print]

PMID:
30092696
4.

Baseline NAWM structural integrity and CBF predict periventricular WMH expansion over time.

Promjunyakul NO, Dodge HH, Lahna D, Boespflug EL, Kaye JA, Rooney WD, Silbert LC.

Neurology. 2018 Jun 12;90(24):e2119-e2126. doi: 10.1212/WNL.0000000000005684. Epub 2018 May 16.

5.

Risk Factors Associated with Cortical Thickness and White Matter Hyperintensities in Dementia Free Okinawan Elderly.

Silbert LC, Lahna D, Promjunyakul NO, Boespflug E, Ohya Y, Higashiuesato Y, Nishihira J, Katsumata Y, Tokashiki T, Dodge HH.

J Alzheimers Dis. 2018;63(1):365-372. doi: 10.3233/JAD-171153.

6.

MR Imaging-based Multimodal Autoidentification of Perivascular Spaces (mMAPS): Automated Morphologic Segmentation of Enlarged Perivascular Spaces at Clinical Field Strength.

Boespflug EL, Schwartz DL, Lahna D, Pollock J, Iliff JJ, Kaye JA, Rooney W, Silbert LC.

Radiology. 2018 Feb;286(2):632-642. doi: 10.1148/radiol.2017170205. Epub 2017 Aug 29.

7.

Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease.

Dodge HH, Zhu J, Woltjer R, Nelson PT, Bennett DA, Cairns NJ, Fardo DW, Kaye JA, Lyons DE, Mattek N, Schneider JA, Silbert LC, Xiong C, Yu L, Schmitt FA, Kryscio RJ, Abner EL; SMART data consortium.

Alzheimers Dement. 2017 Jun;13(6):613-623. doi: 10.1016/j.jalz.2016.11.003. Epub 2016 Dec 23.

8.

Comparison of cerebral blood flow and structural penumbras in relation to white matter hyperintensities: A multi-modal magnetic resonance imaging study.

Promjunyakul NO, Lahna DL, Kaye JA, Dodge HH, Erten-Lyons D, Rooney WD, Silbert LC.

J Cereb Blood Flow Metab. 2016 Sep;36(9):1528-36. doi: 10.1177/0271678X16651268. Epub 2016 Jun 7.

9.

Less Daily Computer Use is Related to Smaller Hippocampal Volumes in Cognitively Intact Elderly.

Silbert LC, Dodge HH, Lahna D, Promjunyakul NO, Austin D, Mattek N, Erten-Lyons D, Kaye JA.

J Alzheimers Dis. 2016;52(2):713-7. doi: 10.3233/JAD-160079.

10.

Surgery is associated with ventricular enlargement as well as cognitive and functional decline.

Schenning KJ, Murchison CF, Mattek NC, Silbert LC, Kaye JA, Quinn JF.

Alzheimers Dement. 2016 May;12(5):590-7. doi: 10.1016/j.jalz.2015.10.004. Epub 2015 Nov 25.

11.

Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures.

Promjunyakul N, Lahna D, Kaye JA, Dodge HH, Erten-Lyons D, Rooney WD, Silbert LC.

Neuroimage Clin. 2015 Apr 22;8:224-9. doi: 10.1016/j.nicl.2015.04.012. eCollection 2015.

12.

Role of soluble epoxide hydrolase in age-related vascular cognitive decline.

Nelson JW, Young JM, Borkar RN, Woltjer RL, Quinn JF, Silbert LC, Grafe MR, Alkayed NJ.

Prostaglandins Other Lipid Mediat. 2014 Oct;113-115:30-7. doi: 10.1016/j.prostaglandins.2014.09.003. Epub 2014 Sep 30.

13.

The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: evidence of validity.

Frisoni GB, Jack CR Jr, Bocchetta M, Bauer C, Frederiksen KS, Liu Y, Preboske G, Swihart T, Blair M, Cavedo E, Grothe MJ, Lanfredi M, Martinez O, Nishikawa M, Portegies M, Stoub T, Ward C, Apostolova LG, Ganzola R, Wolf D, Barkhof F, Bartzokis G, DeCarli C, Csernansky JG, deToledo-Morrell L, Geerlings MI, Kaye J, Killiany RJ, Lehéricy S, Matsuda H, O'Brien J, Silbert LC, Scheltens P, Soininen H, Teipel S, Waldemar G, Fellgiebel A, Barnes J, Firbank M, Gerritsen L, Henneman W, Malykhin N, Pruessner JC, Wang L, Watson C, Wolf H, deLeon M, Pantel J, Ferrari C, Bosco P, Pasqualetti P, Duchesne S, Duvernoy H, Boccardi M; EADC-ADNI Working Group on The Harmonized Protocol for Manual Hippocampal Volumetry and for the Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Feb;11(2):111-25. doi: 10.1016/j.jalz.2014.05.1756. Epub 2014 Sep 27.

14.

At the interface of sensory and motor dysfunctions and Alzheimer's disease.

Albers MW, Gilmore GC, Kaye J, Murphy C, Wingfield A, Bennett DA, Boxer AL, Buchman AS, Cruickshanks KJ, Devanand DP, Duffy CJ, Gall CM, Gates GA, Granholm AC, Hensch T, Holtzer R, Hyman BT, Lin FR, McKee AC, Morris JC, Petersen RC, Silbert LC, Struble RG, Trojanowski JQ, Verghese J, Wilson DA, Xu S, Zhang LI.

Alzheimers Dement. 2015 Jan;11(1):70-98. doi: 10.1016/j.jalz.2014.04.514. Epub 2014 Jul 9. Review.

15.

Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease.

Dodge HH, Zhu J, Harvey D, Saito N, Silbert LC, Kaye JA, Koeppe RA, Albin RL; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2014 Nov;10(6):690-703. doi: 10.1016/j.jalz.2014.04.513. Epub 2014 Jul 9.

16.

TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.

Gallagher MD, Suh E, Grossman M, Elman L, McCluskey L, Van Swieten JC, Al-Sarraj S, Neumann M, Gelpi E, Ghetti B, Rohrer JD, Halliday G, Van Broeckhoven C, Seilhean D, Shaw PJ, Frosch MP, Alafuzoff I, Antonell A, Bogdanovic N, Brooks W, Cairns NJ, Cooper-Knock J, Cotman C, Cras P, Cruts M, De Deyn PP, DeCarli C, Dobson-Stone C, Engelborghs S, Fox N, Galasko D, Gearing M, Gijselinck I, Grafman J, Hartikainen P, Hatanpaa KJ, Highley JR, Hodges J, Hulette C, Ince PG, Jin LW, Kirby J, Kofler J, Kril J, Kwok JB, Levey A, Lieberman A, Llado A, Martin JJ, Masliah E, McDermott CJ, McKee A, McLean C, Mead S, Miller CA, Miller J, Munoz DG, Murrell J, Paulson H, Piguet O, Rossor M, Sanchez-Valle R, Sano M, Schneider J, Silbert LC, Spina S, van der Zee J, Van Langenhove T, Warren J, Wharton SB, White CL 3rd, Woltjer RL, Trojanowski JQ, Lee VM, Van Deerlin V, Chen-Plotkin AS.

Acta Neuropathol. 2014 Mar;127(3):407-18. doi: 10.1007/s00401-013-1239-x. Epub 2014 Jan 19.

17.

Plasma omega-3 PUFA and white matter mediated executive decline in older adults.

Bowman GL, Dodge HH, Mattek N, Barbey AK, Silbert LC, Shinto L, Howieson DB, Kaye JA, Quinn JF.

Front Aging Neurosci. 2013 Dec 16;5:92. doi: 10.3389/fnagi.2013.00092. eCollection 2013.

18.

Neuropathologic basis of white matter hyperintensity accumulation with advanced age.

Erten-Lyons D, Woltjer R, Kaye J, Mattek N, Dodge HH, Green S, Tran H, Howieson DB, Wild K, Silbert LC.

Neurology. 2013 Sep 10;81(11):977-83. doi: 10.1212/WNL.0b013e3182a43e45. Epub 2013 Aug 9.

19.

Neuropathologic basis of age-associated brain atrophy.

Erten-Lyons D, Dodge HH, Woltjer R, Silbert LC, Howieson DB, Kramer P, Kaye JA.

JAMA Neurol. 2013 May;70(5):616-22. doi: 10.1001/jamaneurol.2013.1957.

20.

Trajectory of white matter hyperintensity burden preceding mild cognitive impairment.

Silbert LC, Dodge HH, Perkins LG, Sherbakov L, Lahna D, Erten-Lyons D, Woltjer R, Shinto L, Kaye JA.

Neurology. 2012 Aug 21;79(8):741-7. doi: 10.1212/WNL.0b013e3182661f2b. Epub 2012 Jul 25.

21.

Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging.

Bowman GL, Silbert LC, Howieson D, Dodge HH, Traber MG, Frei B, Kaye JA, Shannon J, Quinn JF.

Neurology. 2012 Jan 24;78(4):241-9. doi: 10.1212/WNL.0b013e3182436598. Epub 2011 Dec 28.

22.

Neuroimaging and cognition in Parkinson's disease dementia.

Silbert LC, Kaye J.

Brain Pathol. 2010 May;20(3):646-53. doi: 10.1111/j.1750-3639.2009.00368.x. Review.

23.

Cognitive impairment risk: white matter hyperintensity progression matters.

Silbert LC, Howieson DB, Dodge H, Kaye JA.

Neurology. 2009 Jul 14;73(2):120-5. doi: 10.1212/WNL.0b013e3181ad53fd.

24.

Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline.

Silbert LC, Nelson C, Howieson DB, Moore MM, Kaye JA.

Neurology. 2008 Jul 8;71(2):108-13. doi: 10.1212/01.wnl.0000316799.86917.37.

25.

Trajectories of brain loss in aging and the development of cognitive impairment.

Carlson NE, Moore MM, Dame A, Howieson D, Silbert LC, Quinn JF, Kaye JA.

Neurology. 2008 Mar 11;70(11):828-33. Epub 2007 Nov 28.

PMID:
18046010
26.

Does statin use decrease the amount of Alzheimer disease pathology in the brain?

Silbert LC.

Neurology. 2007 Aug 28;69(9):E8-11. No abstract available.

PMID:
17724280
27.

Brain volumes in Guam dementia vs Parkinson dementia complex vs aging Chamorro adults.

Kaye JA, Moore MM, Galasko D, Craig UK, Adonay R, Silbert LC.

Neurology. 2007 Jul 10;69(2):196-9.

PMID:
17620553
28.

Cortical excitability and age-related volumetric MRI changes.

Silbert LC, Nelson C, Holman S, Eaton R, Oken BS, Lou JS, Kaye JA.

Clin Neurophysiol. 2006 May;117(5):1029-36. Epub 2006 Mar 27.

PMID:
16564739
29.

Changes in premorbid brain volume predict Alzheimer's disease pathology.

Silbert LC, Quinn JF, Moore MM, Corbridge E, Ball MJ, Murdoch G, Sexton G, Kaye JA.

Neurology. 2003 Aug 26;61(4):487-92.

PMID:
12939422
30.

Natural history of cognitive decline in the old old.

Howieson DB, Camicioli R, Quinn J, Silbert LC, Care B, Moore MM, Dame A, Sexton G, Kaye JA.

Neurology. 2003 May 13;60(9):1489-94.

PMID:
12743237
31.

Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease.

Montine TJ, Quinn JF, Milatovic D, Silbert LC, Dang T, Sanchez S, Terry E, Roberts LJ 2nd, Kaye JA, Morrow JD.

Ann Neurol. 2002 Aug;52(2):175-9.

PMID:
12210787

Supplemental Content

Loading ...
Support Center